-
Je něco špatně v tomto záznamu ?
Aryl hydrocarbon receptor and aryl hydrocarbon nuclear translocator expression in human and rat placentas and transcription activity in human trophoblast cultures
L. Stejskalova, L. Vecerova, LM. Peréz, R. Vrzal, Z. Dvorak, P. Nachtigal, P. Pavek
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 1996 do Před 1 rokem
Open Access Digital Library
od 1996-01-01
Medline Complete (EBSCOhost)
od 1998-01-01 do Před 1 rokem
PubMed
21666223
DOI
10.1093/toxsci/kfr150
Knihovny.cz E-zdroje
- MeSH
- aktivace transkripce účinky léků fyziologie MeSH
- aromatické hydroxylasy genetika metabolismus MeSH
- choriokarcinom farmakoterapie genetika metabolismus MeSH
- dospělí MeSH
- gestační stáří MeSH
- krysa rodu rattus MeSH
- lidé MeSH
- messenger RNA metabolismus MeSH
- nádorové buněčné linie MeSH
- potkani Wistar MeSH
- receptory aromatických uhlovodíků - jaderný translokátor genetika metabolismus MeSH
- receptory aromatických uhlovodíků genetika metabolismus MeSH
- těhotenství MeSH
- trofoblasty účinky léků metabolismus MeSH
- vývojová regulace genové exprese MeSH
- xenobiotika toxicita MeSH
- zvířata MeSH
- Check Tag
- dospělí MeSH
- krysa rodu rattus MeSH
- lidé MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Aryl hydrocarbon receptor (AHR) and its heterodimer aryl hydrocarbon nuclear translocator (ARNT) form a ligand-activated transcription complex that regulates expression of the AHR battery of target genes that includes the most important placental biotransformation enzyme cytochrome CYP1A1. Expression, placental localization, and ontogeny of AHR/Ahr and ARNT/Arnt have not been systematically studied in either human or rat placentas. Moreover, induction of such AHR target genes as CYP1A1, CYP1A2, CYP1B1, UGT1A1, and breast cancer resistance protein (BCRP), as well as of AHR, ARNT, and aryl hydrocarbon receptor repressor (AHRR) genes, after exposure to AHR ligands have not been studied in human placental trophoblast cultures. In this article, we show that only CYP1A1 messenger RNA (mRNA), but not CYP1A2, CYP1B1, UGT1A1, BCRP, AHR, ARNT, and AHRR mRNAs, is significantly induced in human term placental trophoblast cultures after exposure to prototype AHR ligands/activators 2,3,7,8-tetrachlorodibenzo-p-dioxin, 3-methylcholanthrene, omeprazole, and β-naphthoflavone. We localized AHR/Ahr and ARNT/Arnt in rat placental trophoblasts throughout gestation and in first trimester and term human placental trophoblast, which comprise the crucial component of the maternal-fetal barrier. We demonstrate that rat Ahr and Cyp1a1 reached highest expression during gestation days 15 and 18, which might indicate different response to Ahr ligands in placental Cyp1a1 induction during rat gestation. We also propose the JEG3 choriocarcinoma cell line as a cellular model for human trophoblast induction studies through AHR. In conclusion, we describe expression and ontogeny of AHR/Ahr and ARNT/Arnt and systematically characterize induction of major AHR target genes in human placental trophoblast forming the placental maternal-fetal morphological and metabolic barrier.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12028257
- 003
- CZ-PrNML
- 005
- 20130417204538.0
- 007
- ta
- 008
- 120817e20110610xxu f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1093/toxsci/kfr150 $2 doi
- 035 __
- $a (PubMed)21666223
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Stejskalová, Lucie $7 xx0142114 $u Department of Pharmacology and Toxicology, Charles University in Prague, Hradec Kralove, Czech Republic.
- 245 10
- $a Aryl hydrocarbon receptor and aryl hydrocarbon nuclear translocator expression in human and rat placentas and transcription activity in human trophoblast cultures / $c L. Stejskalova, L. Vecerova, LM. Peréz, R. Vrzal, Z. Dvorak, P. Nachtigal, P. Pavek
- 520 9_
- $a Aryl hydrocarbon receptor (AHR) and its heterodimer aryl hydrocarbon nuclear translocator (ARNT) form a ligand-activated transcription complex that regulates expression of the AHR battery of target genes that includes the most important placental biotransformation enzyme cytochrome CYP1A1. Expression, placental localization, and ontogeny of AHR/Ahr and ARNT/Arnt have not been systematically studied in either human or rat placentas. Moreover, induction of such AHR target genes as CYP1A1, CYP1A2, CYP1B1, UGT1A1, and breast cancer resistance protein (BCRP), as well as of AHR, ARNT, and aryl hydrocarbon receptor repressor (AHRR) genes, after exposure to AHR ligands have not been studied in human placental trophoblast cultures. In this article, we show that only CYP1A1 messenger RNA (mRNA), but not CYP1A2, CYP1B1, UGT1A1, BCRP, AHR, ARNT, and AHRR mRNAs, is significantly induced in human term placental trophoblast cultures after exposure to prototype AHR ligands/activators 2,3,7,8-tetrachlorodibenzo-p-dioxin, 3-methylcholanthrene, omeprazole, and β-naphthoflavone. We localized AHR/Ahr and ARNT/Arnt in rat placental trophoblasts throughout gestation and in first trimester and term human placental trophoblast, which comprise the crucial component of the maternal-fetal barrier. We demonstrate that rat Ahr and Cyp1a1 reached highest expression during gestation days 15 and 18, which might indicate different response to Ahr ligands in placental Cyp1a1 induction during rat gestation. We also propose the JEG3 choriocarcinoma cell line as a cellular model for human trophoblast induction studies through AHR. In conclusion, we describe expression and ontogeny of AHR/Ahr and ARNT/Arnt and systematically characterize induction of major AHR target genes in human placental trophoblast forming the placental maternal-fetal morphological and metabolic barrier.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a aromatické hydroxylasy $x genetika $x metabolismus $7 D001189
- 650 _2
- $a receptory aromatických uhlovodíků - jaderný translokátor $x genetika $x metabolismus $7 D051784
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a choriokarcinom $x farmakoterapie $x genetika $x metabolismus $7 D002822
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a vývojová regulace genové exprese $7 D018507
- 650 _2
- $a gestační stáří $7 D005865
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a messenger RNA $x metabolismus $7 D012333
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a receptory aromatických uhlovodíků $x genetika $x metabolismus $7 D018336
- 650 _2
- $a aktivace transkripce $x účinky léků $x fyziologie $7 D015533
- 650 _2
- $a trofoblasty $x účinky léků $x metabolismus $7 D014327
- 650 _2
- $a xenobiotika $x toxicita $7 D015262
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zemánková, Lenka $7 xx0095412
- 700 1_
- $a Peréz, Laura Mesa
- 700 1_
- $a Vrzal, Radim $7 xx0118949
- 700 1_
- $a Dvořák, Zdeněk, $d 1974- $7 xx0118950
- 700 1_
- $a Nachtigal, Petr $7 uk2009304471
- 700 1_
- $a Pávek, Petr $7 xx0093070
- 773 0_
- $w MED00007104 $t Toxicological sciences : an official journal of the Society of Toxicology $x 1096-0929 $g Roč. 123, č. 1 (20110610), s. 26-36
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21666223 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20130417204836 $b ABA008
- 999 __
- $a ok $b bmc $g 950299 $s 785603
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 123 $c 1 $d 26-36 $e 20110610 $i 1096-0929 $m Toxicological sciences $n Toxicol Sci $x MED00007104
- LZP __
- $a Pubmed-20120817/11/04